Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Our company
  • AZ on the issues
  • Investors
  • Corporate responsibility
  • Newsroom
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
    • Media resources
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• 1
• 2
• 3
• 4
• Next

• • Nov 18, 2008
  • AstraZeneca appoints Rich Fante as President of its U.S. business  
• • Nov 12, 2008
  • Survey shows lung cancer patients blamed for their diagnosis  
• • Nov 9, 2008
  • CRESTOR demonstrates dramatic CV risk reduction in a large statin outcomes study  
• • Oct 30, 2008
  • AstraZeneca PLC third quarter and nine months results 2008  
• • Oct 29, 2008
  • Pivotal data showed SYMBICORT® improved lung function in adults with COPD  
• • Oct 29, 2008
  • AstraZeneca and M.D. Anderson renew cancer research collaboration  
• • Oct 29, 2008
  • American Cancer Society opens doors to AstraZeneca Hope Lodge Center in Boston  
• • Oct 28, 2008
  • AstraZeneca honors 24th annual “Excellence in Chemistry” Award recipients  
• • Oct 15, 2008
  • AstraZeneca and Columbia University Medical Center sign strategic research collaboration in neurosciences  
• • Oct 13, 2008
  • AstraZeneca Survey: Physicians play critical role in helping patients take medicines as prescribed  
• • Oct 10, 2008
  • FDA approves AstraZeneca’s SEROQUEL XR® for the treatment of bipolar depression and bipolar mania  
• • Oct 10, 2008
  • AstraZeneca named a “Top Employer” by Science magazine for 7th consecutive year  
• • Oct 10, 2008
  • Statement from AstraZeneca and Bovis Lend Lease on accident in Waltham, MA  
• • Oct 3, 2008
  • AstraZeneca commends bipartisan efforts to increase access to health coverage for patients with mental illnesses  
• • Sep 23, 2008
  • AstraZeneca recognized as one of Working Mother Magazine’s “100 Best Companies”  
• • Sep 23, 2008
  • US Court denies Teva’s Motion for Summary Judgment in PULMICORT RESPULES® patent litigation  
• • Sep 22, 2008
  • AstraZeneca receives six months pediatric exclusivity for CASODEX® (bicalutamide) from the FDA  
• • Sep 15, 2008
  • AstraZeneca and Targacept announce top-line results from Phase IIb study of AZD3480 in Alzheimer’s disease  
• • Sep 10, 2008
  • Newly released data on onset of effect and patient perception with SYMBICORT® in adults with asthma  
• • Sep 10, 2008
  • National survey reveals contradictory awareness levels of high cholesterol and atherosclerosis among Hispanic Americans  

• Pages
• 1
• 2
• 3
• 4
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed